Parents are assured that the Sinovac Covid-19 vaccine for children and adolescents is safe with more than 63 million doses having been administered to the population aged 12 to 17 years in China.

Pharmaniaga Bhd in a statement today said the Adverse Events Following Immunisation (AEFI) analysis of 63 million vaccinations suggested that the Sinovac vaccine has an overall good safety profile amongst the child population and the data collected were mainly routine injection site events with normal symptoms...